Wolverine Trading
BLCM

Wolverine Trading’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Wolverine Trading’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,020
Closed -$30K – 5546
2018
Q4 		$30K Sell
1,020
-1,320
-56% -$58.6K ﹤0.01% 4240
2018
Q3 		$144K Buy
+2,340
New +$158K ﹤0.01% 4406

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wolverine Trading's BLCM Position: Q3 2019 in Review

Wolverine Trading sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2019, closing a stake of 1,797 shares — an estimated $31K sold.

Wolverine Trading first reported a position in BLCM in Q3 2018 and held it in 2 quarters. The position peaked at $130K in Q3 2018. 67 funds tracked by Wall St. Rank hold BLCM as of Q3 2019.

  • Wolverine Trading reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Wolverine Trading sold 1,797 Bellicum Pharmaceuticals, Inc. shares in Q3 2019, an estimated $31K.
  • Wolverine Trading first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2018 and held it in 2 quarters.
  • Wolverine Trading's Bellicum Pharmaceuticals, Inc. position peaked at $130K in Q3 2018.
  • 67 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2019.

Based on Wolverine Trading's 13F filing for Q3 2019, filed 14 Nov 2019.